| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Departments of Anatomy and Cell Biology (G.M., T.B., O.K.V., S.O.D.) and Biochemistry and Molecular Biology (A.P.D., T.F.), University of Bergen, N-5009 Bergen, Norway
Address all correspondence and requests for reprints to: Dr. Stein Ove Døskeland, Department of Anatomy and Cell Biology, University of Bergen, Årstadveien 19, N-5009 Bergen, Norway. E-mail: stein.doskeland{at}med.uib.no
cAMP and Ca2+ acted together with the acute phase cytokine interleukin-1ß (IL-1ß) to inhibit hepatocyte DNA replication. At sub-basal activity of cAMP-dependent protein kinase (PKA), neither IL-1ß nor the Ca2+-elevating hormone vasopressin affected hepatocyte proliferation. Basal level of PKA activity permitted IL-1ß action. Increased PKA activity also permitted vasopressin action and sensitized further towards IL-1ß, which acted at 1050 pM concentrations. Vasopressin acted via Ca2+/calmodulin-dependent protein kinase II (CaMKII), and its action was mimicked by the serine/threonine phosphatase inhibitor microcystin, which activates CaMKII. Inhibitors (KN93 and KT5926) of CaMKII selectively counteracted the effects of vasopressin and microcystin on hepatocyte proliferation at concentrations similar to those required to inhibit CaMKII in vitro. Two-dimensional gel electrophoresis of 32P-prelabeled hepatocytes revealed a common set of proteins phosphorylated in response to vasopressin and microcystin. Their phosphorylation was counteracted by CaMKII inhibitor (KT5926). Phosphorylation of the CaMKII substrate phenylalanine hydroxylase (PAH; EC 1.14.16.1) was used as an endogenous marker of CaMKII activation. It was found that treatment of the cells with vasopressin or microcystin increased the phosphorylation of PAH, and that the vasopressin-induced PAH phosphorylation was inhibited by KT5926. In conclusion, the Ca2+-elevating hormone vasopressin potentiated the antiproliferative effects of cAMP and IL-1ß through CaMKII activation.
This article has been cited by other articles:
![]() |
Y.-J. Qu, V. E. Bondarenko, C. Xie, S. Wang, M. S. Awayda, H. C. Strauss, and M. J. Morales W-7 modulates Kv4.3: pore block and Ca2+-calmodulin inhibition Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2364 - H2377. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Fassett, D. Tobolt, and L. K. Hansen Type I Collagen Structure Regulates Cell Morphology and EGF Signaling in Primary Rat Hepatocytes through cAMP-dependent Protein Kinase A Mol. Biol. Cell, January 1, 2006; 17(1): 345 - 356. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-K. R. Larsen, M. T. N. Moller, H. Blankson, H. R. Samari, L. Holden, and P. O. Seglen Naringin-sensitive Phosphorylation of Plectin, a Cytoskeletal Cross-linking Protein, in Isolated Rat Hepatocytes J. Biol. Chem., September 13, 2002; 277(38): 34826 - 34835. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. E. Fladmark, O. T. Brustugun, G. Mellgren, C. Krakstad, R. Boe, O. K. Vintermyr, H. Schulman, and S. O. Doskeland Ca2+/Calmodulin-dependent Protein Kinase II Is Required for Microcystin-induced Apoptosis J. Biol. Chem., January 18, 2002; 277(4): 2804 - 2811. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |